- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-33-0027209

Medigrowth Pharmaceuticals Private Limited
About Medigrowth Pharmaceuticals Private Limited
Data last updated:
Medigrowth Pharmaceuticals Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U52520MH2020PTC344305. Its GSTIN is 27AANCM7164R1ZF (Maharashtra). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Rajesh Kuparam Choudhary and Ashok Akalecha.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Navi Mumbai, Maharashtra.
As per the financials filed for FY 2023, the company reported a revenue of ₹21.48 Lakh, a growth of 64% compared to the previous year. For the same year it recorded a net profit of ₹51,496 (net margin 2.4%) and EBITDA of ₹70,925 (EBITDA margin 3.3%).
Medigrowth Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0027209).
Company details
Recognitions & Rankings of Medigrowth Pharmaceuticals
Contact details
Medigrowth Pharmaceuticals Private Limited's registered office is in Navi Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No – 2 3 & 4 Office No – 624 Sector – 19A The Bombay Oil Seeds & Exchange Premises, Vashi, Navi Mumbai, Maharashtra, India – 400705
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Medigrowth Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medigrowth Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medigrowth Pharmaceuticals Private Limited, buy the company report.
Financials of Medigrowth Pharmaceuticals Private Limited
FY 2023 filings availableMedigrowth Pharmaceuticals Private Limited reported revenue of ₹21.48 Lakh (up 64% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 64% in the latest year. EBITDA rose 107% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹21.48 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹70,925 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹51,496 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 3.3% | ||
| Net Profit Margin | 2.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Medigrowth Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medigrowth Pharmaceuticals Private Limited
Medigrowth Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kuparam Choudhary | Director | 23 Aug 2020 | 6 Years 2 Months | Current |
| Ashok Akalecha | Director | 31 Dec 2021 | 4 Years 10 Months | Current |
Peer comparison
Medigrowth Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mundus Pharmaceuticals Private Limited | ₹21.58 Lakh (FY 2024) | -11.0% | Lucknow, Uttar Pradesh, India | |||
| Medigrowth Pharmaceuticals Private Limitedthis company | ₹21.48 Lakh (FY 2023) | ₹51,496 | 2.4% | 64.0% | Navi Mumbai, Maharashtra, India | |
| J. K. Lifescience Private Limited | ₹21.42 Lakh (FY 2025) | -27.0% | Silvassa, Dadra and Nagar Haveli, India | |||
| Myeliyon Pharmaceutical Private Limited | ₹21.42 Lakh (FY 2021) | 8.0% | Chl, Opp W.E High (Mumbai), Maharashtra, India | |||
| Daswell Pharmaceuticals Private Limited | ₹21.4 Lakh (FY 2019) | Howrah, West Bengal, India |
To see the full peer comparison of Medigrowth Pharmaceuticals Private Limited, buy the company report.
Auditor
Medigrowth Pharmaceuticals Private Limited is audited by Vikram Choudhary & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vikram Choudhary & Co | FY 2023 | 030965C |
Shareholding
The shareholding of Medigrowth Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Medigrowth Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medigrowth Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medigrowth Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medigrowth Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
GST
Medigrowth Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AANCM7164R1ZF | Maharashtra | Active | 04 Sep 2020 |
| 24AANCM7164R2ZK | Gujarat | Active | 28 Nov 2022 |
To see the full GST registrations and return filing status of Medigrowth Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medigrowth Pharmaceuticals Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Veena Choudhary ceased to be Director on 25 Jul 2022.
Frequently asked questions
Medigrowth Pharmaceuticals is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 August 2020 (6+ years old) and is registered under CIN U52520MH2020PTC344305.
Medigrowth Pharmaceuticals has 2 current directors:
- Rajesh Kuparam Choudhary - Director
- Ashok Akalecha - Director
The latest financial statements of Medigrowth Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Medigrowth Pharmaceuticals is 27AANCM7164R1ZF, registered in Maharashtra. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 24AANCM7164R2ZK (Gujarat).
The CIN (Corporate Identification Number) of Medigrowth Pharmaceuticals is U52520MH2020PTC344305. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medigrowth Pharmaceuticals was incorporated on 23 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Medigrowth Pharmaceuticals by revenue are Mundus Pharmaceuticals Private Limited, J. K. Lifescience Private Limited, Myeliyon Pharmaceutical Private Limited, Daswell Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Veena Choudhary ceased to be Director on 25 Jul 2022. Ashok Akalecha was appointed as Director on 31 Dec 2021. Rajesh Kuparam Choudhary was appointed as Director on 23 Aug 2020.
Yes, Medigrowth Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0027209).
The registered office of Medigrowth Pharmaceuticals is at Plot No – 2 3 & 4 Office No – 624 Sector – 19A The Bombay Oil Seeds & Exchange Premises, Vashi, Navi Mumbai, Maharashtra, India – 400705.
Medigrowth Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

